Claudin-5 levels are reduced in human end-stage cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 1, 2008, Pages 81-87

  Mays, Tessily A ^a   Binkley, Philip F ^a,b   Lesinski, Amanda ^a,b   Doshi, Amit A ^a,b   Quaile, Michael P ^c   Margulies, Kenneth B ^c   Janssen, Paul M L ^a,b   Rafael Fortney, Jill A ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiomyopathy; Cell junction; Claudin 5; Dystrophin; Heart failure

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CLAUDIN 5; CONNEXIN 43; DESMOPLAKIN; DYSTROPHIN; NERVE CELL ADHESION MOLECULE; PLAKOGLOBIN;

ARTICLE; CARDIOMYOPATHY; CELL JUNCTION; CONTROLLED STUDY; DISEASE SEVERITY; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ANIMALS; ANTIGENS, CD; CADHERINS; CARDIOMYOPATHIES; CATENINS; CONNEXIN 43; DESMOPLAKINS; FEMALE; GAP JUNCTIONS; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MUSCLE PROTEINS; MYOCYTES, CARDIAC; TIGHT JUNCTIONS;

MURINAE;

EID: 45549098124     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.04.005     Document Type: Article

References (33)

1. Towbin J.A., and Bowles N.E. The failing heart. Nature 415 (2002) 227-233
2. Ehler E., Horowits R., Zuppinger C., Price R.L., Perriard E., Leu M., et al. Alterations at the intercalated disk associated with the absence of muscle LIM protein. J. Cell Biol. 153 (2001) 763-772
3. Ferreira-Cornwell M.C., Luo Y., Narula N., Lenox J.M., Lieberman M., and Radice G.L. Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J. Cell Sci. 115 (2002) 1623-1634
4. Li J., Patel V.V., Kostetskii I., Xiong Y., Chu A.F., Jacobson J.T., et al. Cardiac-specific loss of N-cadherin leads to alteration in connexins with conduction slowing and arrhythmogenesis. Circ. Res. 97 (Sep 2 2005) 474-481
5. Perriard J.C., Hirschy A., and Ehler E. Dilated cardiomyopathy: a disease of the intercalated disc?. Trends Cardiovasc. Med. 13 (2003) 30-38
6. Li J., Patel V.V., and Radice G.L. Dysregulation of cell adhesion proteins and cardiac arrhythmogenesis. Clin. Med. Res. (Mar 4 2006) 42-52
7. Maeda M., Holder E., Lowes B., Valent S., and Bies R.D. Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. Circulation 95 (1997) 17-20
8. Schaper J., Froede R., Hein S., Buck A., Hashizume H., Speiser B., et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 83 (1991) 504-514
9. Dupont E., Matsushita T., Kaba R.A., Vozzi C., Coppen S.R., Khan N., et al. Altered connexin expression in human congestive heart failure. J. Mol. Cell Cardiol. 33 (2001 Feb) 359-371
10. Peters N.S., Green C.R., Poole-Wilson P.A., and Severs N.J. Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation 88 (Sep 1993) 864-875
11. Kostin S., Rieger M., Dammer S., Hein S., Richter M., Klovekorn W.P., et al. Gap junction remodeling and altered connexin43 expression in the failing human heart. Mol. Cell Biochem. 242 (2003 Jan) 135-144
12. Protonotarios N.I., Tsatsopoulou A.A., and Gatzoulis K.A. Arrhythmogenic right ventricular cardiomyopathy caused by a deletion in plakoglobin (Naxos disease). Card. Electrophysiol. Rev. 6 (2002) 72-80
13. McGrath J.A. Inherited disorders of desmosomes. Australas. J. Dermatol. 46 (Nov 2005) 221-229
14. Sanford J.L., Edwards J.D., Mays T.A., Gong B., Merriam A.P., and Rafael-Fortney J.A. Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in utrophin/dystrophin-deficient cardiomyopathic mice. J. Mol. Cell Cardiol. 38 (Feb 2005) 323-332
15. Hainsey T.A., Senapati S., Kuhn D.E., and Rafael J.A. Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature. Neuromuscul. Disord. 13 (2003) 294-302
16. Deconinck A.E., Rafael J.A., Skinner J.A., Brown S.C., Potter A.C., Metzinger L., et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90 (1997) 717-727
17. Janssen P.M., Hiranandani N., Mays T.A., and Rafael-Fortney J.A. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. Am. J. Physiol. Heart Circ. Physiol. 289 (Dec 2005) H2373-H2378
18. Kostin S., Dammer S., Hein S., Klovekorn W.P., Bauer E.P., and Schaper J. Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc. Res. 62 (May 1 2004) 426-436
19. Vatta M., Stetson S.J., Perez-Verdia A., Entman M.L., Noon G.P., Torre-Amione G., et al. Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet 359 (Mar 16 2002) 936-941
20. Jesaitis L.A., and Goodenough D.A. Molecular characterization and tissue distribution of ZO-2, a tight junction protein homologous to ZO-1 and the Drosophila discs-large tumor suppressor protein. J. Cell Biol. 124 (Mar 1994) 949-961
21. Inoko A., Itoh M., Tamura A., Matsuda M., Furuse M., and Tsukita S. Expression and distribution of ZO-3, a tight junction MAGUK protein, in mouse tissues. Genes. Cells 8 (Nov 2003) 837-845
22. Kostin S. Zonula occludens-1 and connexin 43 expression in the failing human heart. J. Cell Mol. Med. 11 (Jul-Aug 2007) 892-895
23. Laing J.G., Saffitz J.E., Steinberg T.H., and Yamada K.A. Diminished zonula occludens-1 expression in the failing human heart. Cardiovasc. Pathol. 16 (May-Jun 2007) 159-164
24. Hewitt K.J., Agarwal R., and Morin P.J. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6 (2006) 186
25. Miyamori H., Takino T., Kobayashi Y., Tokai H., Itoh Y., Seiki M., et al. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J. Biol. Chem. 276 (Jul 27 2001) 28204-28211
26. Yang Y., Estrada E.Y., Thompson J.F., Liu W., and Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. (Jul 19 2006)
27. Oku N., Sasabe E., Ueta E., Yamamoto T., and Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res. 66 (2006 May 15) 5251-5257
28. Schwartzkopff B., Fassbach M., Pelzer B., Brehm M., and Strauer B.E. Elevated serum markers of collagen degradation in patients with mild to moderate dilated cardiomyopathy. Eur. J. Heart Fail. 4 (Aug 2002) 439-5254
29. Thomas C.V., Coker M.L., Zellner J.L., Handy J.R., Crumbley III A.J., and Spinale F.G. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 97 (May 5 1998) 1708-1715
30. Tiyyagura S.R., and Pinney S.P. Left ventricular remodeling after myocardial infarction: past, present, and future. Mt. Sinai. J. Med. 73 (Oct 2006) 840-851
31. Gallagher G.L., Jackson C.J., and Hunyor S.N. Myocardial extracellular matrix remodeling in ischemic heart failure. Front. Biosci. 12 (2007) 1410-1419
32. Lindsay E.A. Chromosomal microdeletions: dissecting del22q11 syndrome. Nat. Rev. Genet. 2 (2001) 858-868
33. Sirotkin H., Morrow B., Saint-Jore B., Puech A., Das Gupta R., Patanjali S.R., et al. Identification, characterization, and precise mapping of a human gene encoding a novel membrane-spanning protein from the 22q11 region deleted in velo-cardio-facial syndrome. Genomics 42 (1997) 245-251